NEW DELHI, April 7, 2026 — Surishi Pharmaceuticals Pvt. Ltd., a pioneering women’s healthcare company headquartered in New Delhi, is taking a bold step forward bringing the emerging science of cellular longevity directly into the conversation around women’s health in India. As the global medical community increasingly recognises NAD⁺ (Nicotinamide Adenine Dinucleotide) depletion as a …



